of March 31, 2025 or December 31, 2024 were in a continuous unrealized loss position for greater than 12 months. The decline in fair value below amortized cost basis was not attributed to credit-related factors and it is more likely than not that the Company will hold the securities until maturity or a recovery of the cost basis. No credit-related impairment losses were recorded as of March 31, 2025 or December 31, 2024. All of the Company’s U.S. Treasury securities had contractual maturities due within one year as of March 31, 2025 and December 31, 2024.
Equity Securities
The Company holds equity securities in publicly-traded companies, which are recorded at fair market value each reporting period in marketable securities on the condensed consolidated balance sheets. Realized and unrealized gains and losses are recorded in other income (expense), net on the condensed consolidated statements of operations. For the three months ended March 31, 2025 and 2024, net unrealized losses from publicly-traded equity securities held at the end of each period were $
10.7
million and $
10.9
million, respectively.
The Company also holds equity securities in privately-held companies without readily determinable fair values that are recorded using the measurement alternative. As of March 31, 2025 and December 31, 2024, the total amount of privately-held equity securities included in other assets on the consolidated balance sheets was $
104.5
million and $
64.9
million, respectively. The Company classifies these fair value measurements as Level 3 within the fair value hierarchy. The Company recorded upward adjustments of $
4.7
million due to observable price changes and no material downward adjustments or impairments for the privately-held equity securities during the three months ended March 31, 2025; and did not record any material adjustments or impairments for the privately-held equity securities during the three months ended  March 31, 2024. Cumulative downward adjustments and impairments were not material and cumulative upward adjustments were $
4.7
million on privately-held equity securities held by the Company as of March 31, 2025.
Additionally, we have accepted, and may continue to accept, securities as noncash consideration. Total equity securities received as noncash consideration was $
6.2
million and $
10.9
million during the three months ended March 31, 2025 and 2024, respectively.
11
Table of contents
Palantir Technologies Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
Strategic Commercial Contracts
From 2021 through 2022, the Company approved and entered into certain agreements (“Investment Agreements”) to purchase shares of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee,” and such purchases, the “Investments”).
No
Investments were purchased under such Investment Agreements during the three months ended March 31, 2025 or the fiscal